Delivery Order SPE2DB24D2018-SPE2DB25FWWQ2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,463.80 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a pharmaceutical product used in anticoagulation therapy. This competitively awarded, firm fixed-price delivery order was issued on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract includes no set-aside designation, indicating that...
- The Defense Logistics Agency awarded a delivery order valued at $16,287.19 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a pharmaceutical product for anticoagulation therapy. This competitive award, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,827.12 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract. The delivery order was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-competitive, competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a $9,868.31 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. This competitive delivery order, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, carries firm fixed pricing and represents a child contract under AmerisourceBergen's broader pharmaceutical supply vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a $15,808.62 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. The contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025, and carries firm fixed pricing under a non-set-aside competitive award. Performance of the contract is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,347.12 to AmerisourceBergen Drug Corp for 60-tablet bottles of Eliquis 5 mg tablets, with an ultimate completion date of September 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on September 4, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $22,144.15 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a pharmaceutical product commonly used for anticoagulation therapy. The award was made on September 3, 2025, with an ultimate completion date of September 4, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded under open procurement procedures. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,065.95 for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This competitive award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, carries a firm fixed price structure with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this delivery order from...
- The Defense Logistics Agency awarded a $6,744.00 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, with an ultimate completion date of September 10, 2025. This competitive award, issued on September 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the pharmaceutical distributor maintains operations as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $18,393.96 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a pharmaceutical product used in anticoagulation therapy. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWWQ2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,357.73 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a pharmaceutical product used in anticoagulation therapy. This non-set-aside, competitively awarded delivery order features firm fixed pricing and was completed on September 9, 2025, one day after the award date of September 8, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Through this contract vehicle, AmerisourceBergen provides critical pharmaceutical products and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 9/8/25 |